Major trial confirms value of zoledronic acid dosed every 3 months in preventing pain, SREs

Posted on June 17, 2015 by Sitemaster

An interesting paper that we managed to miss at the recent annual meeting of the American Society of Clinical Oncology (ASCO) provided the results of a large, randomized clinical trial of the use of zoledronic acid, carried out by the Cancer and Leukemia Group B cooperative trial group. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: , , , , , , , | Leave a comment »

Results of the RADAR trial at 7.4 years of follow-up

Posted on August 22, 2014 by Sitemaster

The RADAR trial (also known as TROG 03.04) was a randomized trial of 6 months of androgen deprivation therapy (ADT) + radiation therapy versus 18 months of ADT + radiotherapy, with or without additional zoledronic acid therapy, in men with intermediate- and high-risk, locally advanced prostate cancer. … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , , , | 6 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives